Athero Review - Issue 3/2020

Editorial

141
Editorial

Michal Vrablík


Guidelines

147
Genetic testing of familial hypercholesterolemia in clinical practice: statement of Czech Society for Atherosclerosis

Michal Vrablík, Vladimír Bláha, Renata Cífková, Tomáš Freiberger, David Karásek, Pavel Kraml, Jan Piťha, Hana Rosolová, Vladimír Soška, Tomáš Štulc, Lukáš Tichý, Zuzana Urbanová Za Výbor Čsat, Jana Mašková


Reviews

158
Impact of SGLT2 inhibitors and real clinical practice

Branislav Vohnout, Jana Lisičanová, Andrea Havranová

163
Hypertriglyceridemia – today and tomorrow

Martin Šatný, Michal Vrablík

168
Selected biomarkers associated with atherosclerosis and bone metabolism

Katarína Demková, Ivan Tkáč


173
Patient variability in nutritional case reports

Věra Boháčová, Tamara Starnovská


176
Mendelian randomisation studies: principle and selected examples from cardiovascular medicine

Jaroslav A. Hubáček

181
GLP-1 receptor agonists: antidiabetic agents with antiatherogenic effect

Ivan Tkáč

185
LIPIcontrol 2 what has changed after 3 years

Martin Šatný, Michal Vrablík

191
Novinky v liečbe evolokumabom: komentár k štúdiam VESALIUS-CV a FOURIER

Ivan Tkáč

194
News in the treatment with alirocumab presented in the congress of European Society of Cardiology 2020: comment on post-hoc analysis of the ODYSSEY OUTCOMES trial

Ivan Tkáč


197
A little change in payment means a big chance for a lot of ills

Lucie Ondřichová


From scholarly literature

200
Rešerše zajímavých článků ze zahraniční literatury

Eva Tůmová


202
Professor Rudolf Poledne eighty-year old

Jan Piťha


Annoucements

203
Šobrův den 2020: XXXIV. konference o hyperlipoproteinemiích tentokrát virtuálně

Kristýna Čillíková


Login
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account